Shivalik Rasayan Ltd have successfully submitted USMDF for API Palbociclib to US-FDA
Venus Remedies receives new marketing authorization for Docetaxel and Gemcitabine
Venus Remedies Limited has announced the successful receipt of new marketing authorizations for DOCETAXEL in concentrations of 160MG/8ML, 20MG/1 ML and 80MG/4ML(SingleVlal), as well as GEMCITABINE 1G from Malta, Europe.
These approvals signify the commitment to expanding its pharmaceutical portfolio and market presence. The company looks forward to leveraging these authorizations to enhance its global reach and contribute to the advancement of healthcare solutions.
Shivalik Rasayan submits USMDF for API 'Palbociclib’
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA. The Palbociclib is used for Breast Cancer and is under Patent in US till 2026.
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
